The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors Mar 26, 2025 08:00AM
Concerned Shareholder Group Calls for Atea Pharmaceuticals to Appoint a New, Shareholder-Oriented Lead Independent Director to Oversee Strategic Review Process Dec 18, 2024 05:05PM
Form SC 13D/A Atea Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP Nov 28, 2023 06:23AM
Atea Pharmaceuticals' (AVIR) Board of Directors Unanimously Rejects Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences May 30, 2023 07:03AM
Atea Pharmaceuticals’ Board of Directors Unanimously Rejects Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences May 30, 2023 07:00AM


May 23, 2023 04:05PM Atea Pharmaceuticals (AVIR) Confirms $5.75/sh + CVR Acquisition Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
May 23, 2023 04:05PM Atea Pharmaceuticals Confirms Receipt of Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
May 22, 2023 09:00AM Form SC 13D Atea Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP